跳至主要内容
临床试验/JPRN-UMIN000002438
JPRN-UMIN000002438已完成4 期

A prospective, open, randomized and comparative trial of the efficacy of a fixed-dose losartan/hydrochlorothiazide (Preminent) versus high-dose amlodipine using home blood pressure monitoring in the treatment of hypertension: ALPHABET Study - ALPHABET Study

Jichi Medical University0 个研究点目标入组 100 人开始时间: 2009年9月3日最近更新:
适应症

试验速览

阶段
4 期
状态
已完成
入组人数
100

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 80years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1) Patients with uncontrolled hypertension (DBP>120mmHg) 2) Patients with uncontrolled diabetes (HbAlc>8.0%) 3) History of myocardial infarction, cerebrocascular accidents or other bascular accidents within 3months prior to the screening 4) patients with cardiac insufficiency (over NYHA grade III) 5) Oatients with a precious history of gout attack or uncontrolled hyperuricemia (UA>8.0mg/dl) 6) Patients with renal failure (serum creatinine>2.0mg/dl) 7) Hepatic dysfunction (AST and/or ALT>100IU/l) 8) Patients with secondary hypertension (bilateral renal artery stenosis, primary aldosteronism, etc 9) Patients with malignant hypertension 10) Pregnant women and women of childbearing potential 11) History of serious adverse drug reaction to study drugs 12) The patient for whom it is difficult to receive informed consent (dementia, etc) 13) Other patients who are judged to be inappropriate for the study by the inverstigator

研究者

相似试验